In comparison with the mammary carcinoma cell line MCF7, which served as positive control and was set as 100%, the mean expression levels in the carcinomas were 183% for ERK1 (range 1–863%) and 80% for ERK2 (range 1–314%). This evidence concerns the gene MAPK1 and carcinoma.